Two novel promoters in the upstream regulatory region of human papillomavirus type 31b are negatively regulated by epithelial differentiation

Journal of Virology

Volumn 73, Issue 4, 1999, Pages 3505-3510

  Ozbun, Michelle A ^a   Meyers, Craig ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; HUMAN PAPILLOMA VIRUS 31B; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REGULATOR GENE; REGULATORY MECHANISM; RNA SEQUENCE; SEQUENCE ANALYSIS; TISSUE DIFFERENTIATION; VIRUS GENOME; WART VIRUS;

EID: 0032976578     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.4.3505-3510.1999     Document Type: Article

References (26)

1. Androphy, E. J., D. R. Lowy, and J. T. Schiller. 1987. Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature (London) 325:70-73.
2. Baker, C. C., and P. M. Howley. 1987. Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues. EMBO J. 6:1027-1035.
3. Bedell, M. A., J. B. Hudson, T. R. Golub, M. E. Turyk, M. Hosken, G. D. Wilbanks, and L. A. Laimins. 1991. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J. Virol. 65:2254-2260.
4. Cripe, T. P., T. H. Haugen, J. P. Turk, F. Tabatabai, P. G. Schmid III, M. Dürst, L. Gissmann, A. Roman, and L. P. Turek. 1987. Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis. EMBO J. 6:3745-3753.
5. Crum, C. P., G. Nuovo, D. Friedman, and S. J. Silverstein. 1988. Accumulation of RNA homologous to human papillomavirus type 16 open reading frames in genital precancers. J. Virol. 62:84-90.
6. Gloss, B., H. U. Bernard, K. Seedorf, and G. Klock. 1987. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J. 6:3735-3743.
7. Goldsborough, M. D., D. DiSilvestre, G. F. Temple, and A. T. Lorincz. 1989. Nucleotide sequence of human papillomavirus type 31: a cervical neoplasia-associated virus. Virology 171:306-311.
8. Howley, P. M. 1996. Papillomavirinae: the viruses and their replication, p. 2045-2076. In B. N. Fields and D. M. Knipe (ed.), Fields virology, 3rd ed. Raven Press, New York, N.Y.
9. Hummel, M., J. B. Hudson, and L. A. Laimins. 1992. Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J. Virol. 66:6070-6080.
10. Hummel, M., H. B. Lim, and L. A. Laimins. 1995. Human papillomavirus type 31b late gene expression is regulated through protein kinase C-mediated changes in RNA processing. J. Virol. 69:3381-3388.
11. Kozak, M. 1991. Structural features in eukaryotic mRNAs that modulate the initiation of translation. J. Biol. Chem. 266:19867-19870.
12. Lorincz, A. T., R. Reid, A. B. Jenson, M. D. Greenburg, W. Lancaster, and R. J. Kurman. 1992. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol. 79:328-337.
13. Mayer, T. J., and C. Meyers. 1998. Temporal and spatial expression of the E5a protein during the differentiation-dependent life cycle of human papillomavirus type 31b. Virology 248:208-218.
14. Meyers, C., M. G. Frattini, J. B. Hudson, and L. A. Laimins. 1992. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257:971-973.
15. Meyers, C., T. J. Mayer, and M. A. Ozbun. 1997. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J. Virol. 71:7381-7386.
16. Ozbun, M. A., and C. Meyers. 1996. Transforming growth factor β1 induces differentiation in human papillomavirus-positive keratinocytes. J. Virol. 70: 5437-5446.
17. Ozbun, M. A., and C. Meyers. 1997. Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J. Virol. 71:5161-5172.
18. Ozbun, M. A., and C. Meyers. 1998. Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification. Virology 248:218-230.
19. Ozbun, M. A., and C. Meyers. 1998. Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b. J. Virol. 72:2715-2722.
20. Palermo-Dilts, D. A., T. R. Broker, and L. T. Chow. 1990. Human papillomavirus type 1 produces redundant as well as polycistronic mRNAs in plantar warts. J. Virol. 64:3144-3149.
21. Rheinwald, J. G., and M. A. Beckett 1981. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res. 41:1657-1663.
22. Smale, S. T. 1994. Core promoter architecture for eukaryotic protein-coding sequences, p. 63-81. In R. C. Conway and J. W. Conway (ed.), Transcription mechanisms and regulation. Raven Press, New York, N.Y.
23. Stoler, M. H., S. M. Wolinsky, A. Whitbeck, T. R. Broker, and L. T. Chow. 1989. Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 172:331-340.
24. Stubenrauch, F., J. Malejczyk, P. G. Fuchs, and H. Pfisler. 1992. Late promoter of human papillomavirus type 8 and its regulation. J. Virol. 66: 3485-3493.
25. Taichman, L. B., and R. F. LaPorta. 1987. The expression of papillomaviruses in epithelial cells, p. 109-139. In N. P. Salzman and P. M. Howley (ed.), The Papovaviridae, vol 2. The papillomaviruses. Plenum Press, New York, N.Y.
26. Wettstein, F. O., M. S. Barbosa, and M. Nasseri. 1987. Identification of the major cottontail rabbit papillomavirus late RNA cap site and mapping and quantitation of an E2 and minor E6 coding mRNA in papillomas and carcinomas. Virology 159:321-328.